Published in Cancer Weekly, September 20th, 1999
Researcher M.G. Tovey and colleagues from Villejuif's Cancer Research Institute examined mucosal cytokine activity in this murine study ("Mucosal Cytokine Therapy: Marked Antiviral and Antitumor Activity," Journal of Interferon Cytokine Research, August 1999;19(8):911-921).
Mucosal administration of the Th1 stimulatory cytokines interleukin-2 (IL-2), IL-12, IL-15, IL-18, or granulocyte-macrophage colony-stimulating factor (GM-CSF) induced antiviral activity in mice challenged systemically with a lethal dose of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.